OBJECTIVE: To study the possible role of human β-defensins 1 (Hbd-1) and immunoglobulins A, G and M (IgA, IgG and IgM) in the development of recurrent pneumonia by measuring serum concentrations of the above indexes in infants with recurrent pneumonia and healthy infants. METHODS: Serum samples were obtained from 35 healthy children and 35 children aged from 2 to 24 months with recurrent pneumonia. Serum Hbd-1 concentration was measured using ELISA. Serum IgA, IgG and IgM concentrations were measured by immunonephelometry. The correlation of hBD-1 with IgA, IgG and IgM was evaluated. RESULTS: The serum concentration of hBD-1 in infants with recurrent pneumonia (14±11 μg/mL) was significantly lower than in controls (18±11 μg/mL) (P0.05). CONCLUSIONS: The serum levels of hBD-1, IgA and IgG decrease in infants with recurrent pneumonia, suggesting disorders in the immune defensive function of the respiratory tract, and this may be one of the immunity related reasons for recurrent pneumonia in infants. It is of great clinical value to measure serum levels of Hbd-1, IgA, IgG and IgM in infants with recurrent pneumonia.
Key words
Recurrent pneumonia /
Human β-defensins 1 /
Immunoglobulin /
Infant
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
［1］陈慧中，胡仪吉．如何认识反复呼吸道感染［J］．中华儿科杂志，2008，46（2）：83-84．
［2］胡仪吉.全国小儿呼吸道疾病学术会议纪要［J］．中华儿科杂志，1988，26（1）：41-42．
［3］韩瑞珠，郝艳艳，侯安存．反复呼吸道感染儿童细胞免疫与体液免疫［J］．实用儿科临床杂志，2007，26（10）：736-737．
［4］Prado Montes de Oca E. Human beta-defensin 1: a restless warrior against allergies, infections and cancer［J］. Int J Biochem Cell Biol, 2010, 42(6): 800-804.
［5］中华医学会儿科学会呼吸学组.儿童社区获得性肺炎管理指南（试行）（上）［J］.中华儿科杂志, 2007, 45(2): 83-90.
［6］中华医学会儿科学会呼吸学组.反复呼吸道感染的临床概念和处理原则［J］.中华儿科杂志, 2008, 46(2):108-110.
［7］Diamond G, Kaiser V, Rhodes J, Russell JP, Bevins CL. Transcriptional regulation of beta defensin gene expression in tracheal epithelial cells［J］. Infect Immun, 2000, 68(1):113-119.
［8］侯松萍，董震，潘留兰．卡介苗吸入对LPS致肺炎大鼠肺β-防御素mRNA的影响［J］.免疫学杂志, 2006, 22(5): 573-576.
［9］冯云，黄宁，吴琦，王伯徭．卡介苗胞壁蛋白诱导人肺腺上皮细胞hBD-1 mRNA表达及其抗菌活性的增强［J］. 中华微生物学和免疫学杂志，2001，21（4）：400-403.
［10］Matsushita I, Hasegawa K, Nakata K, Yasuda K, Tokunaga K, Keicho N. Genetic variants of human beta-defensin-1 and chronic obstructive pulmonary disease［J］. Biochem Biophys Res Commun, 2002, 291(1): 17-22.
［11］都勇，孙书明，李玉．肿瘤坏死因子-a，人类β-防御索-1基因多态性与慢性阻塞性肺病相关性的研究［J］. 中国临床医学，2008，15：329-331．
［12］Yang D, Chertov O, Bykovskaia SN, Chen Q, Buffo MJ, Shogan J, et al. Beta-defensin: linking innate and adaptive immunity through dendritic and T cell CCR6［J］. Science, 1999, 286(5439): 525-528.
［13］Yang D, Liu ZH, Tewary P, Chen Q, de la Rosa G, Oppenheim JJ. Defensin participation in innate and adaptive immunity［J］. Curr Pharm Des, 2007, 13(30): 3131-3139.
［14］胡学亭，李玉娟，李晓营，刘瑞文．肺炎支原体肺炎患儿补体及免疫球蛋白检测及临床分析［J］. 中国当代儿科杂志，2009，11（11）：933-934.
PDF(905 KB)
